Canada markets closed

Orchard Therapeutics plc (ORTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.4800-0.0100 (-2.04%)
At close: 04:00PM EDT
0.5292 +0.05 (+10.25%)
After hours: 07:18PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 60.41M
Enterprise Value -77.81M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.48
Price/Book (mrq)0.34
Enterprise Value/Revenue -10.81
Enterprise Value/EBITDA 0.52

Trading Information

Stock Price History

Beta (5Y Monthly) 1.19
52-Week Change 3-90.91%
S&P500 52-Week Change 3-7.05%
52 Week High 35.6300
52 Week Low 30.4100
50-Day Moving Average 30.6474
200-Day Moving Average 31.4690

Share Statistics

Avg Vol (3 month) 3600.38k
Avg Vol (10 day) 3601.72k
Shares Outstanding 5125.91M
Implied Shares Outstanding 6N/A
Float 872.71M
% Held by Insiders 10.42%
% Held by Institutions 144.97%
Shares Short (Apr 28, 2022) 4777.94k
Short Ratio (Apr 28, 2022) 41.58
Short % of Float (Apr 28, 2022) 4N/A
Short % of Shares Outstanding (Apr 28, 2022) 40.62%
Shares Short (prior month Mar 30, 2022) 41.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,952.37%

Management Effectiveness

Return on Assets (ttm)-25.81%
Return on Equity (ttm)-65.23%

Income Statement

Revenue (ttm)7.2M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-85.53M
EBITDA -138.01M
Net Income Avi to Common (ttm)-153.7M
Diluted EPS (ttm)-1.2090
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)199.02M
Total Cash Per Share (mrq)1.58
Total Debt (mrq)60.8M
Total Debt/Equity (mrq)34.61
Current Ratio (mrq)5.06
Book Value Per Share (mrq)1.39

Cash Flow Statement

Operating Cash Flow (ttm)-105.45M
Levered Free Cash Flow (ttm)-74.59M